Fair Drug Prices and the Patent System
Health Care Analysis 12 (2):91-115 (2004)
| Abstract | This paper uses John Rawls' theory of justice to defend the patent system against charges that it has an unfair effect on access to medications, from the perspective of national and international justice. The paper argues that the patent system is fair in a national context because it respects intellectual property rights and it benefits the least advantaged members of society by providing incentives for inventors, investors, and entrepreneurs. The paper also argues that the patent system is fair in an international context, provided that developed nations take steps to help disease-stricken countries secure internal justice. Fairness in a national or international context also requires that the patent system should include emergency exceptions to deal with short-term inequities | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,672 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesSigrid Sterckx (2005). Can Drug Patents Be Morally Justified? Science and Engineering Ethics 11 (1).
Darryl J. Murphy (2012). Are Intellectual Property Rights Compatible with Rawlsian Principles of Justice? Ethics and Information Technology 14 (2):109-121.
R. Stephen Crespi (2005). Ethico-Legal Issues in Biomedicine Patenting: A Patent Professional Viewpoint. Science and Engineering Ethics 11 (1).
Sigrid Sterckx (2004). A Critique of the Utilitarian Argument for the Patent System. Philosophy in the Contemporary World 11 (2):81-88.
Sigrid Sterckx (2004). A Critique of the Utilitarian Argument for the Patent System. Philosophy in the Contemporary World 11 (2):81-88.
Alex Rosenberg (2004). On the Priority of Intellectual Property Rights, Especially in Biotechnology. Politics, Philosophy and Economics 3 (1):77-95.
Samantha Byrne, Paul Davey, Kirsti McFarlane, John O'Brien & Craig Templeton (2006). Patent Rights or Patent Wrongs? The Case of Patent Rights on AIDS Drugs. Business Ethics 15 (3):299–305.
Ramona Albin (2010). Patents, Innovation, and Privatization. Science and Engineering Ethics 16 (4):777-781.
Rebecca S. Eisenberg (2002). How Can You Patent Genes? American Journal of Bioethics 2 (3):3 – 11.
Analytics
Monthly downloads |
Added to index2010-08-24Total downloads9 ( #114,013 of 549,068 )Recent downloads (6 months)1 ( #63,185 of 549,068 )How can I increase my downloads? |
My notes
Discussion
